Transnational Drug Trafficking Act of 2015
Amends the Controlled Substances Import and Export Act to prohibit the manufacture or distribution of a controlled substance in schedule I or II, flunitrazepam, or a listed chemical by individuals having reasonable cause to believe that such substance or chemical will be unlawfully imported into the United States or into waters within 12 miles of the U.S. coast.
Prohibits the manufacture or distribution of a listed chemical: (1) intending or knowing that it will be used to manufacture a controlled substance; and (2) intending, knowing, or having reasonable cause to believe that the substance will be unlawfully imported into the United States.
Amends the federal criminal code to revise the prohibition against, and penalties for, intentionally trafficking in a counterfeit drug to apply to intentionally trafficking in a drug and knowingly using a counterfeit mark on or in connection with such drug.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2016-05-16 | President | Became Public Law No: 114-154. | House floor actions |
| 2016-05-16 | President | Signed by President. | House floor actions |
| 2016-05-13 | Floor | Presented to President. | House floor actions |
| 2016-05-10 | Floor | Motion to reconsider laid on the table Agreed to without objection. | House floor actions |
| 2016-05-10 | Floor | On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2175) | House floor actions |
| 2016-05-10 | Floor | DEBATE - The House proceeded with forty minutes of debate on S. 32. | House floor actions |
| 2016-05-10 | Floor | Considered under suspension of the rules. (consideration: CR H2175-2179) | House floor actions |
| 2016-05-10 | Floor | Mr. Goodlatte moved to suspend the rules and pass the bill. | House floor actions |
| 2015-11-17 | Committee | Committee on United States Senate Caucus on International Narcotics Control. Hearings held. | Senate |
| 2015-11-03 | Committee | Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. | House committee actions |
| 2015-10-09 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2015-10-08 | IntroReferral | Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2015-10-08 | IntroReferral | Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2015-10-08 | Floor | Message on Senate action sent to the House. | Senate |
| 2015-10-08 | Floor | Received in the House. | House floor actions |
| 2015-10-07 | Floor | Passed Senate without amendment by Unanimous Consent. (consideration: CR S7223; text as passed Senate: CR S7223) | Senate |
| 2015-09-17 | Calendars | Placed on Senate Legislative Calendar under General Orders. Calendar No. 232. | Senate |
| 2015-09-17 | Committee | Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report. | Senate |
| 2015-09-17 | Committee | Committee on the Judiciary. Ordered to be reported without amendment favorably. | Senate |
| 2015-01-13 | IntroReferral | Referred to the Committee on the Judiciary by unanimous consent. | Senate |
| 2015-01-13 | Discharge | Senate Committee on Finance discharged by Unanimous Consent. | Senate |
| 2015-01-06 | IntroReferral | Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S18-19) | Senate |
| 2015-01-06 | IntroReferral | Introduced in Senate | Library of Congress |